⌕
VIR Biotechnology · VIR · Nasdaq
Tenet 54 · Mixed
Compare
$9.25−3.44%At closeTenet 54 · Mixed
$9.25−0.33 (−3.44%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

VIR Biotechnology (VIR) Institutional Ownership

13F filers reported holding 13.1% of VIR Biotechnology (VIR) shares as of Sep 30, 2026, across 104 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
13.1%
Sep 30, 2026
13F filers
104
quarter ended Sep 30, 2026
13F value
$251.4M
22.5M shares
Quarter's fund flow
Mild accumulation
22 new · 4 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (22 new · 32 increased · 33 reduced · 4 closed · 13 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 104 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 3, 2026de Verneuil VaninaEVP, General Counsel, Corp SecDisposed · Open-market sale2,407Common Stock$11.10↗
Nov 2, 2026de Verneuil VaninaEVP, General Counsel, Corp SecDisposed · Open-market sale1,343Common Stock$11.33↗
Oct 27, 2026Topalian Suzanne LouisedirectorAcquired · Grant / award8,000Common Stock—↗
Oct 27, 2026Topalian Suzanne LouisedirectorAcquired · Grant / award4,731Common Stock—↗
Oct 27, 2026Topalian Suzanne LouisedirectorAcquired · Grant / award16,000Stock Option (Right to Buy)—↗
Oct 27, 2026Topalian Suzanne LouisedirectorAcquired · Grant / award9,462Stock Option (Right to Buy)—↗
Aug 11, 2026MORE ROBERT JdirectorDisposed · Other8,000—↗
Aug 11, 2026MORE ROBERT JdirectorAcquired · Other8,000—↗
Jun 9, 2026Coughlin Timothy PdirectorAcquired · Grant / award8,000Common Stock—↗
Jun 9, 2026Coughlin Timothy PdirectorAcquired · Grant / award8,000Common Stock—↗
Jun 9, 2026Coughlin Timothy PdirectorAcquired · Grant / award16,000Stock Option (Right to Buy)—↗
Jun 9, 2026Coughlin Timothy PdirectorAcquired · Grant / award16,000Stock Option (Right to Buy)—↗
Jun 1, 2026Napolitano JanetdirectorDisposed · Open-market sale3,200$9.45↗
Jun 1, 2026Sabatini BrentSVP, Chief Accounting OfficerDisposed · Open-market sale379Common Stock$9.45↗
May 27, 2026Sigal Charles ElliottdirectorAcquired · Grant / award8,000—↗
May 27, 2026Sigal Charles ElliottdirectorAcquired · Grant / award16,000Stock Option (Right to Buy)—↗
May 27, 2026Napolitano JanetdirectorAcquired · Grant / award8,000—↗
May 27, 2026Napolitano JanetdirectorAcquired · Grant / award16,000Stock Option (Right to Buy)—↗
May 27, 2026MORE ROBERT JdirectorAcquired · Grant / award8,000—↗
May 27, 2026MORE ROBERT JdirectorAcquired · Grant / award16,000Stock Option (Right to Buy)—↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of VIR Biotechnology do institutions hold?

13F filers reported holding 13.1% of VIR Biotechnology's shares as of Sep 30, 2026, across 104 filers.

How many 13F filers hold VIR Biotechnology?

VIR Biotechnology was held by 104 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.